Intellia Therapeutics, Inc. (NTLA)

CIK 1652130 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Intellia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001193125-26-385194
Sep 4, 20268-K0001193125-26-383645
Aug 24, 202640001193125-26-363567
Aug 20, 20261440001969223-26-000938
Aug 7, 2026SCHEDULE 13G0000093751-26-000484
Aug 6, 20268-K0001193125-26-336772
Aug 6, 202610-Q0001193125-26-337952
Jul 24, 202640001193125-26-316279
Jul 6, 202640001821530-26-000002
Jul 6, 202640002019493-26-000002
Jul 2, 20261440001950047-26-006836
Jun 15, 20268-K0001193125-26-270358
Jun 10, 202640001193125-26-266230
Jun 10, 202640001563572-26-000001
Jun 10, 20268-K0001193125-26-265934
Jun 10, 202640001193125-26-266241
Jun 10, 202640001193125-26-266233
Jun 10, 202640001193125-26-266236
Jun 10, 202640001756929-26-000002
Jun 10, 202640001545794-26-000001
May 11, 20268-K0001193125-26-215721
May 11, 202610-Q0001193125-26-215740
Apr 30, 2026DEFA14A0001193125-26-197355
Apr 30, 20268-K0001193125-26-197489
Apr 30, 2026SCHEDULE 13G0002100119-26-000581